Primary hepatic epithelioid hemangioendothelioma progressively responsive to interferon-alpha: is there room for novel anti-angiogenetic treatments?

Calabrò, L; Di Giacomo, A M; Altomonte, M; Fonsatti, E; Mazzei, M A; Volterrani, L; Miracco, C; Maio, M

Calabrò, L; Di Giacomo, A M; Altomonte, M; Fonsatti, E; Mazzei, M A; Volterrani, L; Miracco, C; Maio, M.

Affiliation

Calabrò L; Division of Medical Oncology and Immunotherapy, Department of Oncology University Hospital of Siena, Siena, Italy.

J Exp Clin Cancer Res ; 26(1): 145-50, 2007 Mar.

Article in En | MEDLINE | ID: mdl-17550144

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Hemangioendothelioma, Epithelioid/drug therapy; Interferon-alpha/therapeutic use; Liver Neoplasms/drug therapy; Neovascularization, Pathologic/prevention & control; Antigens, CD/analysis; Antigens, CD34/analysis; Endoglin; Female; Hemangioendothelioma, Epithelioid/blood supply; Hemangioendothelioma, Epithelioid/immunology; Hemangioendothelioma, Epithelioid/pathology; Humans; Immunohistochemistry; Interferon alpha-2; Liver Neoplasms/blood supply; Liver Neoplasms/immunology; Liver Neoplasms/pathology; Middle Aged; Neovascularization, Pathologic/immunology; Neovascularization, Pathologic/pathology; Platelet Endothelial Cell Adhesion Molecule-1/analysis; Receptors, Cell Surface/analysis; Recombinant Proteins; Tomography, X-Ray Computed; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Interferon-alpha / Hemangioendothelioma, Epithelioid / Angiogenesis Inhibitors / Liver Neoplasms / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: J Exp Clin Cancer Res Year: 2007 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links